Abbott Laboratories (ABL.DE)
EUR 108.8
(1.25%)
EUR 108.8
(1.25%)
| Breakdown | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 |
|---|---|---|---|---|---|---|
| Operating Cash Flow | 7.26 Billion | 9.58 Billion | 10.53 Billion | 7.9 Billion | 6.13 Billion | 6.3 Billion |
| Net Income | 5.72 Billion | 6.93 Billion | 7.07 Billion | 4.49 Billion | 3.68 Billion | 2.36 Billion |
| Depreciation & Amortization | 3.24 Billion | 3.26 Billion | 3.53 Billion | 3.32 Billion | 3.01 Billion | 3.27 Billion |
| Deferred income taxes | 1.83 Billion | - | - | - | - | 293 Million |
| Stock-based compensation | 644 Million | 685 Million | 640 Million | 546 Million | 519 Million | 477 Million |
| Change in working capital | -2.47 Billion | -1.51 Billion | -771 Million | -892 Million | -1.33 Billion | -148 Million |
| Other non-cash items | -1.7 Billion | 215 Million | 55 Million | 425 Million | 247 Million | 32 Million |
| Investing Cash Flow | -3.13 Billion | -1.74 Billion | -2 Billion | -2.21 Billion | -1.81 Billion | -1.35 Billion |
| Investments in PPE | -2.2 Billion | -1.77 Billion | -1.88 Billion | -2.17 Billion | -1.63 Billion | -1.39 Billion |
| Acquisitions | -837 Million | 48 Million | -53 Million | 16 Million | -122 Million | 48 Million |
| Investment purchases | -159 Million | -185 Million | -173 Million | -83 Million | -103 Million | -131 Million |
| Sales/Maturities of investments | 43 Million | 152 Million | 77 Million | 10 Million | 21 Million | 73 Million |
| Other Investing Activities | 22 Million | 22 Million | 26 Million | 19 Million | 27 Million | 48 Million |
| Financing Cash Flow | -7.09 Billion | -7.63 Billion | -5.49 Billion | -2.77 Billion | -4.28 Billion | -10.39 Billion |
| Debt repayment | -2.49 Billion | -753 Million | -48 Million | -1.33 Billion | -3.44 Billion | -12.43 Billion |
| Dividends payments | -3.55 Billion | -3.3 Billion | -3.2 Billion | -2.56 Billion | -2.27 Billion | -1.97 Billion |
| Common Stock Repurchased | -1.22 Billion | -3.79 Billion | -2.29 Billion | -403 Million | -718 Million | -238 Million |
| Common Stock Issuance | 3.72 Billion | - | - | 1.52 Billion | - | - |
| Other Financing Activities | -3.53 Billion | 221 Million | 55 Million | -11 Million | 2.14 Billion | 4.25 Billion |
| Accounts receivables | -356 Million | -68 Million | -383 Million | -924 Million | -275 Million | -190 Million |
| Accounts payables | -760 Million | 420 Million | 1.28 Billion | 1.76 Billion | 220 Million | 747 Million |
| Inventory | -232 Million | -1.41 Billion | -456 Million | -493 Million | -593 Million | -514 Million |
| Other working capital | -1.12 Billion | -458 Million | -1.22 Billion | -1.24 Billion | -683 Million | -191 Million |
| Cash at beginning of period | 9.88 Billion | 9.79 Billion | 6.83 Billion | 3.86 Billion | 3.84 Billion | 9.4 Billion |
| Cash at end of period | 6.89 Billion | 9.88 Billion | 9.79 Billion | 6.83 Billion | 3.86 Billion | 3.84 Billion |
| Capital Expenditure | -2.2 Billion | -1.77 Billion | -1.88 Billion | -2.17 Billion | -1.63 Billion | -1.39 Billion |
| Effect of forex changes on cash | -23 Million | -122 Million | -70 Million | 71 Million | -16 Million | -116 Million |
| Net cash flow / Change in cash | -2.98 Billion | 83 Million | 2.96 Billion | 2.97 Billion | 16 Million | -5.56 Billion |
| Free Cash Flow | 5.05 Billion | 7.8 Billion | 8.64 Billion | 5.72 Billion | 4.49 Billion | 4.9 Billion |
| Breakdown | 2024 Q2 | 2024 Q1 | 2023 FY | 2023 Q4 | 2023 Q3 | 2023 Q2 |
|---|---|---|---|---|---|---|
| Operating Cash Flow | - | - | - | - | - | - |
| Net Income | 1.3 Billion | 1.22 Billion | 5.72 Billion | 1.59 Billion | 1.43 Billion | 1.37 Billion |
| Depreciation & Amortization | 805 Million | 805 Million | 3.24 Billion | 813 Million | 824 Million | 800 Million |
| Deferred income taxes | - | - | 1.83 Billion | 1.41 Billion | - | - |
| Stock-based compensation | 141 Million | 304 Million | 644 Million | 114 Million | 117 Million | 132 Million |
| Change in working capital | -428 Million | -561 Million | -2.47 Billion | -1.52 Billion | -321 Million | -444 Million |
| Other non-cash items | 140 Million | -748 Million | -1.7 Billion | 631 Million | -179 Million | -660 Million |
| Investing Cash Flow | -453 Million | -425 Million | -3.13 Billion | -824 Million | -634 Million | -1.21 Billion |
| Investments in PPE | -533 Million | -398 Million | -2.2 Billion | -755 Million | -560 Million | -507 Million |
| Acquisitions | - | - | -837 Million | - | -51 Million | -826 Million |
| Investment purchases | - | - | -159 Million | - | - | - |
| Sales/Maturities of investments | - | - | 43 Million | - | - | - |
| Other Investing Activities | 2 Million | 1 Million | 22 Million | -69 Million | -23 Million | -706 Million |
| Financing Cash Flow | -791 Million | -1.17 Billion | -7.09 Billion | -2.05 Billion | -2.34 Billion | -1.28 Billion |
| Debt repayment | -160 Million | -127 Million | -2.49 Billion | -1.05 Billion | -1.44 Billion | -2 Million |
| Dividends payments | -961 Million | -957 Million | -3.55 Billion | -888 Million | -888 Million | -890 Million |
| Common Stock Repurchased | -3 Million | -226 Million | -1.22 Billion | -259 Million | -2 Million | -426 Million |
| Common Stock Issuance | - | - | 3.72 Billion | 1.31 Billion | - | - |
| Other Financing Activities | 173 Million | 7 Million | -3.53 Billion | -1.16 Billion | -5 Million | 29 Million |
| Accounts receivables | -325 Million | -151 Million | -356 Million | 68 Million | -461 Million | -196 Million |
| Accounts payables | - | - | -760 Million | - | - | - |
| Inventory | -103 Million | -410 Million | -232 Million | 295 Million | 140 Million | -248 Million |
| Other working capital | 140 Million | -748 Million | -1.12 Billion | -1.88 Billion | -179 Million | -660 Million |
| Cash at beginning of period | 6.28 Billion | 6.89 Billion | 9.88 Billion | 6.7 Billion | 7.83 Billion | 9.16 Billion |
| Cash at end of period | 6.98 Billion | 6.28 Billion | 6.89 Billion | 6.89 Billion | 6.7 Billion | 7.83 Billion |
| Capital Expenditure | -533 Million | -398 Million | -2.2 Billion | -755 Million | -560 Million | -507 Million |
| Effect of forex changes on cash | -13 Million | -36 Million | -23 Million | 25 Million | -29 Million | -27 Million |
| Net cash flow / Change in cash | 703 Million | -612 Million | -2.98 Billion | 187 Million | -1.12 Billion | -1.32 Billion |
| Free Cash Flow | 1.42 Billion | 627 Million | 5.05 Billion | 2.28 Billion | 1.31 Billion | 696 Million |
GFPT-R
PAH3
2OY
FDX
300612
NAUT